1. Preface
    1.1. Market Definition and Scope
    1.2. Market Segmentation
    1.3. Key Research Objectives
    1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Brain Implants Market
4. Market Overview
    4.1. Introduction
        4.1.1. Market Definition
    4.2. Overview
    4.3. Market Dynamics
        4.3.1. Drivers
        4.3.2. Restraints
        4.3.3. Opportunities
    4.4. Global Brain Implants Market Analysis and Forecast, 2017–2031
        4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
    5.1. egulatory Scenario
    5.2. Prevalence and Incidence rate of various Neurological Disorders
    5.3. Technological Advancements
6. Global Brain Implants Market Analysis and Forecast, by Product Type
    6.1. Introduction & Definition
    6.2. Key Findings / Developments
    6.3. Market Value Forecast, by Product Type, 2017–2031
        6.3.1. Deep Brain Stimulator
        6.3.2. Vagus Nerve Stimulator
        6.3.3. Spinal Cord Stimulator
    6.4. Market Attractiveness Analysis, by Product Type
7. Global Brain Implants Market Analysis and Forecast, by Application
    7.1. Introduction & Definition
    7.2. Key Findings / Developments
    7.3. Market Value Forecast, by Application, 2017–2031
        7.3.1. Chronic Pain
        7.3.2. Parkinson’s Disease
        7.3.3. Essential Tremor
        7.3.4. Epilepsy
        7.3.5. Depression
        7.3.6. Others
    7.4. Market Attractiveness Analysis, by Application
8. Global Brain Implants Market Analysis and Forecast, by End-user
    8.1. Introduction & Definition
    8.2. Key Findings / Developments
    8.3. Market Value Forecast, by End-user, 2017–2031
        8.3.1. Hospitals
        8.3.2. Specialty Centers
        8.3.3. Others
    8.4. Market Attractiveness Analysis, by End-user
9. Global Brain Implants Market Analysis and Forecast, by Region
    9.1. Key Findings
    9.2. Market Value Forecast, by Region
        9.2.1. North America
        9.2.2. Europe
        9.2.3. Asia Pacific
        9.2.4. Latin America
        9.2.5. Middle East & Africa
    9.3. Market Attractiveness Analysis, by Region
10. North America Brain Implants Market Analysis and Forecast
    10.1. Introduction
        10.1.1. Key Findings
    10.2. Market Value Forecast, by Product Type, 2017–2031
        10.2.1. Deep Brain Stimulator
        10.2.2. Vagus Nerve Stimulator
        10.2.3. Spinal Cord Stimulator
    10.3. Market Value Forecast, by Application, 2017–2031
        10.3.1. Chronic Pain
        10.3.2. Parkinson’s Disease
        10.3.3. Essential Tremor
        10.3.4. Epilepsy
        10.3.5. Depression
        10.3.6. Others
    10.4. Market Value Forecast, by End-user, 2017–2031
        10.4.1. Hospitals
        10.4.2. Specialty Centers
        10.4.3. Others
    10.5. Market Value Forecast, by Country, 2017–2031
        10.5.1. U.S.
        10.5.2. Canada
    10.6. Market Attractiveness Analysis
        10.6.1. By Product Type
        10.6.2. By Application
        10.6.3. By End-user
        10.6.4. By Country
11. Europe Brain Implants Market Analysis and Forecast
    11.1. Introduction
        11.1.1. Key Findings
    11.2. Market Value Forecast, by Product Type, 2017–2031
        11.2.1. Deep Brain Stimulator
        11.2.2. Vagus Nerve Stimulator
        11.2.3. Spinal Cord Stimulator
    11.3. Market Value Forecast, by Application, 2017–2031
        11.3.1. Chronic Pain
        11.3.2. Parkinson’s Disease
        11.3.3. Essential Tremor
        11.3.4. Epilepsy
        11.3.5. Depression
        11.3.6. Others
    11.4. Market Value Forecast, by End-user, 2017–2031
        11.4.1. Hospitals
        11.4.2. Specialty Centers
        11.4.3. Others
    11.5. Market Value Forecast, by Country/Sub-region, 2017–2031
        11.5.1. U.K.
        11.5.2. Germany
        11.5.3. France
        11.5.4. Italy
        11.5.5. Spain
        11.5.6. Rest of Europe
    11.6. Market Attractiveness Analysis
        11.6.1. By Product Type
        11.6.2. By Application
        11.6.3. By End-user
        11.6.4. By Country/Sub-region
12. Asia Pacific Brain Implants Market Analysis and Forecast
    12.1. Introduction
        12.1.1. Key Findings
    12.2. Market Value Forecast, by Product Type, 2017–2031
        12.2.1. Deep Brain Stimulator
        12.2.2. Vagus Nerve Stimulator
        12.2.3. Spinal Cord Stimulator
    12.3. Market Value Forecast, by Application, 2017–2031
        12.3.1. Chronic Pain
        12.3.2. Parkinson’s Disease
        12.3.3. Essential Tremor
        12.3.4. Epilepsy
        12.3.5. Depression
        12.3.6. Others
    12.4. Market Value Forecast, by End-user, 2017–2031
        12.4.1. Hospitals
        12.4.2. Specialty Centers
        12.4.3. Others
    12.5. Market Value Forecast, by Country/Sub-region, 2017–2031
        12.5.1. China
        12.5.2. Japan
        12.5.3. India
        12.5.4. Australia & New Zealand
        12.5.5. Rest of APAC
    12.6. Market Attractiveness Analysis
        12.6.1. By Product Type
        12.6.2. By Application
        12.6.3. By End-user
        12.6.4. By Country/Sub-region
13. Latin America Brain Implants Market Analysis and Forecast
    13.1. Introduction
        13.1.1. Key Findings
    13.2. Market Value Forecast, by Product Type, 2017–2031
        13.2.1. Deep Brain Stimulator
        13.2.2. Vagus Nerve Stimulator
        13.2.3. Spinal Cord Stimulator
    13.3. Market Value Forecast, by Application, 2017–2031
        13.3.1. Chronic Pain
        13.3.2. Parkinson’s Disease
        13.3.3. Essential Tremor
        13.3.4. Epilepsy
        13.3.5. Depression
        13.3.6. Others
    13.4. Market Value Forecast, by End-user, 2017–2031
        13.4.1. Hospitals
        13.4.2. Specialty Centers
        13.4.3. Others
    13.5. Market Value Forecast, by Country/Sub-region, 2017–2031
        13.5.1. Brazil
        13.5.2. Mexico
        13.5.3. rest of LATAM
    13.6. Market Attractiveness Analysis
        13.6.1. By Product Type
        13.6.2. By Application
        13.6.3. By End-user
        13.6.4. By Country/Sub-region
14. Middle East & Africa Brain Implants Market Analysis and Forecast
    14.1. Introduction
        14.1.1. Key Findings
    14.2. Market Value Forecast, by Product Type, 2017–2031
        14.2.1. Deep Brain Stimulator
        14.2.2. Vagus Nerve Stimulator
        14.2.3. Spinal Cord Stimulator
    14.3. Market Value Forecast, by Application, 2017–2031
        14.3.1. Chronic Pain
        14.3.2. Parkinson’s Disease
        14.3.3. Essential Tremor
        14.3.4. Epilepsy
        14.3.5. Depression
        14.3.6. Others
    14.4. Market Value Forecast, by End-user, 2017–2031
        14.4.1. Hospitals
        14.4.2. Specialty Centers
        14.4.3. Others
    14.5. Market Value Forecast, by Country/Sub-region, 2017–2031
        14.5.1. GCC Countries
        14.5.2. South Africa
        14.5.3. Rest of Middle East & Africa
    14.6. Market Attractiveness Analysis
        14.6.1. By Product Type
        14.6.2. By Application
        14.6.3. By End-user
        14.6.4. By Country/Sub-region
15. Competition Landscape
    15.1. Market Player – Competition Matrix (by tier and size of companies)
    15.2. Company Profiles
        15.2.1. Medtronic
            15.2.1.1. Company Overview
            15.2.1.2. Financial Overview
            15.2.1.3. Product Portfolio
            15.2.1.4. Business Strategies
            15.2.1.5. Recent Developments
        15.2.2. Abbott
            15.2.2.1. Company Overview
            15.2.2.2. Financial Overview
            15.2.2.3. Product Portfolio
            15.2.2.4. Business Strategies
            15.2.2.5. Recent Developments
        15.2.3. Boston Scientific Corporation
            15.2.3.1. Company Overview
            15.2.3.2. Financial Overview
            15.2.3.3. Product Portfolio
            15.2.3.4. Business Strategies
            15.2.3.5. Recent Developments
        15.2.4. NeuroPace
            15.2.4.1. Company Overview
            15.2.4.2. Financial Overview
            15.2.4.3. Product Portfolio
            15.2.4.4. Business Strategies
            15.2.4.5. Recent Developments
        15.2.5. Renishaw plc
            15.2.5.1. Company Overview
            15.2.5.2. Financial Overview
            15.2.5.3. Product Portfolio
            15.2.5.4. Business Strategies
            15.2.5.5. Recent Developments
        15.2.6. LivaNova plc
            15.2.6.1. Company Overview
            15.2.6.2. Financial Overview
            15.2.6.3. Product Portfolio
            15.2.6.4. Business Strategies
            15.2.6.5. Recent Developments
        15.2.7. Nevro Corp.
            15.2.7.1. Company Overview
            15.2.7.2. Financial Overview
            15.2.7.3. Product Portfolio
            15.2.7.4. Business Strategies
            15.2.7.5. Recent Developments
*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/


 
			 
					
							
			 
					
							
			 
					
							
			 
					
							
			 
					
							
			 
					
							
			 
					
							
			 
					
							
			